Search by Journal
- HOME
- > Search by Journal
- > Neurological Therapeutics
Neurological Therapeutics
Volume 26, Issue 3 / 2009
English Article Japanese Article
- Please note that metadata of J-type articlesare generated by machine-translation and the original texts are written in Japanese.
Is engaged in the practice of neuromuscular disorders for 38 years; and mainly on - polymyositis / dermatomyositis, clinical analysis of CADASIL, Duchenne muscular dystrophy and a remedial approach - Makoto Uchino Neurological Therapeutics 26(3): 279-280, 2009. |
It is Potential for Therapy of Muscular Dystrophy Systemic Delivery of Genes to Striated Muscles Jeffrey S.Chamberlain*, Paul Gregorevic*, Brian Schultz*, Guy Odom*, Zejing Wang**, Stephen Tapscott*, **, En Kimura*** Neurological Therapeutics 26(3): 281-281, 2009. |
Establishment - of multiple sclerosis (MS) and neuromyelitis optica (NMO)- clinical condition elucidation and the therapy Yasuto Itoyama Neurological Therapeutics 26(3): 282-282, 2009. |
PD, PDD, the prospects to pathology and treatment of DLB Eisaku Ohama Neurological Therapeutics 26(3): 283-283, 2009. |
Topics of stroke treatment Takenori Yamaguchi Neurological Therapeutics 26(3): 284-284, 2009. |
Significance of TDP-43 in the clinical condition elucidation of the ALS Shigeki Kuzuhara Neurological Therapeutics 26(3): 285-285, 2009. |
Gene therapy of the neurologic disease using RNAi Takanori Yokota Neurological Therapeutics 26(3): 286-286, 2009. |
Gene therapy for muscular dystrophy : Mainly in exon skipping 武田伸一 Neurological Therapeutics 26(3): 287-287, 2009. |
Gene therapy of Parkinson disease Hideki Mochizuki Neurological Therapeutics 26(3): 288-288, 2009. |
Development of the therapy for the ALS using the HGF Masashi Aoki, Wariden kernel, Yasuto Itoyama Neurological Therapeutics 26(3): 289-289, 2009. |
Limit of the rt-PA intravenous-injection treatment Teruyuki Hirano Neurological Therapeutics 26(3): 290-290, 2009. |
Thrombolytic therapy and supersonic wave Katsuo Tachibana Neurological Therapeutics 26(3): 291-291, 2009. |
The present conditions and problem of the revascularization in the urgent cerebral blood vessel Keisuke Imai *, Masatsugu Hamanaka ** Neurological Therapeutics 26(3): 292-292, 2009. |
Surgical cure - insatiate challenge - of the stroke Susumu Miyamoto Neurological Therapeutics 26(3): 293-293, 2009. |
Regenerative therapy of cerebrovascular disorder 本望修 *, **, Kiyohiro Hokin ** Neurological Therapeutics 26(3): 294-294, 2009. |
It is a foreword an emcee Shukuro Araki Neurological Therapeutics 26(3): 295-295, 2009. |
Pathologic comparison between amyloid neuropathy - origin-related AL model and familial ATTR type - Shuichi Ikeda Neurological Therapeutics 26(3): 296-296, 2009. |
Prion disease - infection prophylaxis and therapy development - Seiji Yamada Neurological Therapeutics 26(3): 297-297, 2009. |
Progress - of Alzheimer disease - clinical condition elucidation and the treatment study Mikio Shoji Neurological Therapeutics 26(3): 298-298, 2009. |
Transthyretin Tyr114Cys type hereditary brain amyloid angiopathy Taro Yamashita *, Yuki Ando male **, Makoto Uchino * Neurological Therapeutics 26(3): 299-299, 2009. |
Development - of the new therapy not to depend on FAP - liver transplantation Yuki Ando male Neurological Therapeutics 26(3): 300-300, 2009. |
1A-01 renal dysfunction is associated with a poor outcome three months after the cerebral infarction rt-PA intravenous-injection treatment Tadashi Naganuma group, Mayumi Mori, Kazunori Toyota, Masatoshi Koga, Netsu Tomohisa, Takahiro Nakajima, Chiaki Yokota, Kazuo Minematsu Neurological Therapeutics 26(3): 303-303, 2009. |
It is the rt-PA intravenous-injection treatment in the syndrome 3 cases that presented 1A-02 Capsular warning syndrome Masayuki Wakita Neurological Therapeutics 26(3): 303-303, 2009. |
Clinical features of the 1A-03 t-PA mode case Yasuyuki Hara 1, Kuniyasu Wada 1, Shuji Terasaki 1, Teruyuki Hirano 2, Makoto Uchino 2 Neurological Therapeutics 26(3): 304-304, 2009. |
Examination -3 of the rt-PA administration case in the 1A-04 Nippon Medical School neurology affiliated hospital Takaaki Fukuchi 1, Arabian bird Tatsuo 1, Masahiro Mishina 2, Arata Abe 3, Nobuhito Nakajima 4, Masaya Okamura 5, Shiro Kobayashi 2, Tatsuya Nomoto 4, Takehiko Nagao 5, Tairo Katayama 1 Neurological Therapeutics 26(3): 304-304, 2009. |
Present conditions and problem - of the problems - t-PA therapy correspondence hospital of the acceptance system of patients with 1A-05 super-acute-phase cerebral infarction Yasuyuki Iguchi, Ken Shibasaki product, Kazumi Kimura Neurological Therapeutics 26(3): 305-305, 2009. |
Effect of iv-tPA on 1A-06 CT-DWI discrepancy Hiroyuki Kawano 1, 2, Teruyuki Hirano 2, Yuichiro Inatomi 1, Shuji Terasaki 1, Toshiro Yonehara 1, Makoto Uchino 2 Neurological Therapeutics 26(3): 305-305, 2009. |
Analysis of depression and the outcome in the 1A-07 cerebral infarction hyperacuteness period thrombolytic therapy enforcement case Takayoshi Hiroyuki 1, 2, Masao Nagayama 1, 2 Neurological Therapeutics 26(3): 306-306, 2009. |
Does the 1A-08 tPA start of therapy time correlate with a treatment outcome? Masaya Okamura 1, 5, Takehiko Nagao 1, 5, Akane Nogami 1, 5, Masahiro Mishina 2, Tatsuya Nomoto 3, Hiroshi Hagiwara 4, Shiro Kobayashi 2, Tairo Katayama 5, Masayuki Yokochi 1, Hideki Takubo 1 Neurological Therapeutics 26(3): 306-306, 2009. |
Examination of the complications in the t-PA administration case in the 1A-09 this hospital Kenichiro Sakai, Ken Shibasaki product, 貞廣浩和, Nobuyuki Kaneko, 下山隆, Junnya Aoki, Yuka Terasawa, 金哲石, 山下眞史, Masao Watanabe, Takahata wish, Takeshi Iwanaga, Noriko Matsumoto, Yasuyuki Iguchi, Kazumi Kimura Neurological Therapeutics 26(3): 307-307, 2009. |
Thrombolytic therapy for 1A-10 Branch Atheromatous Disease Tsuyoshi Torii, Atsuo Yamada Neurological Therapeutics 26(3): 307-307, 2009. |
Examination of the utility of ozagrel Na and the heparin combination therapy for 1A-11 Branch atheromatous disease Yoshiharu Taguchi, Takashima Shutaro, Shigeo Toyota, Tool Shinko, Koji Hirano, Nukui Takamasa, Kotaro Tanaka Neurological Therapeutics 26(3): 308-308, 2009. |
Examination using the whole blood platelet agglutinating capacity of the clopidogrel unresponsiveness in the 1A-12 ischemic cerebrovascular disease Takuya Fukuoka, Onori Furuya, Hidetaka Takeda, Kimihiko Hattori, 名古屋春満, Yuji Kato, Ichiro Deguchi, Norio Tanahashi Neurological Therapeutics 26(3): 308-308, 2009. |
Antibody therapy for 1B-01 family-related amyloid polyneuropathy (FAP) Yohei Misumi 1, Yuki Ando male 2, Mitsuharu Ueda 2, Hiroshi Kino 2, Great Hikaru Hayashi sense 2, Taro Yamashita 1, Makoto Uchino 1 Neurological Therapeutics 26(3): 309-309, 2009. |
Development of the new therapy for familial amyloid polyneuropathy (FAP) using the 1B-02 cyclodextrin derivative Hiroshi Kino 1, Takayuki Yasuno 2, Yohei Misumi 3, Great Hikaru Hayashi sense 1, Mitsuharu Ueda 1, Bank of a moat Yoko 1, Hidetoshi Arima 1, Yuki Ando male 1 Neurological Therapeutics 26(3): 309-309, 2009. |
1B-03 One case of peripheral neuropathy associated with IgG-κ type M protein production extramedullary plasmacytoma 中野史人1, 矢部一郎1, 松島理明1, 堀内一宏1, 矢口裕章1, 加納崇裕1, 秋本幸子1, 新野正明1, 佐々木秀直1, 丸山覚2, 橋本晃佳2 Neurological Therapeutics 26(3): 310-310, 2009. |
2 cases of the Crow-Fukase syndrome given 1B-04 self peripheral blood stem cell transplantation 冨滿弘之 1, Red locus Saneho 1, Masato Obayashi 1, Tetsuya Fukuda 2, Osamu Miura 2, Takanori Yokota 1, 水澤英洋 1 Neurological Therapeutics 26(3): 310-310, 2009. |
1B-05 One cases of POEMS syndrome associated with IgMλ type primary macroglobulinemia has been remarkable effect Rituximab and thalidomide 中間達也1, 木村円1, 河野和2, 畑裕之2, 丸吉夏英3, 阪本徹郎1, 山下賢1, 平野照之1, 内野誠2 Neurological Therapeutics 26(3): 311-311, 2009. |
The present conditions and the prospects of the new treatment for the 1B-06 POEMS syndrome Satoshi Kuwahara, Sonoko Misawa Neurological Therapeutics 26(3): 311-311, 2009. |
One case of Parkinson disease that periodic limbs exercise during sleep was found in as a prodrome from before more than 1B-07 onset 30 years Jin Abe period, Seki serenity, Takashi Aida Neurological Therapeutics 26(3): 312-312, 2009. |
One case of Parkinson disease that it presented sudden sleep in 1B-08 Pramipexole hydrochloride and changed to ropinirole hydrochloride The Takashi Nakamura sum, Ken Ikeda, Ryuta Sato, 永田梨耶, 岩本康之介, 伊藤裕乃, Yuji Kawase, Rev. Sekine world, Takashi Takasawa period, Kiyoko Murata, Yuichi Ishikawa, Takeshi Miura, Yasuo Iwasaki Neurological Therapeutics 26(3): 312-312, 2009. |
Does the entacapone pharmacokinetics synchronize in 1B-09 L-DOPA absorption delay case? Masahiro Nagai, Hayato Yabe, Noriko Nishikawa, Masahiro Nomoto Neurological Therapeutics 26(3): 313-313, 2009. |
About the effect that 1B-10 Helicobacter pylori sanitization gives for L-dopa absorption Taku Nishida 1, Junichiro Suzuki 1, Yutaka Tsuji length 1, Yasuhiro Ito 1, Takeshi Yasuda 1, Masahiro Nagai 2 Neurological Therapeutics 26(3): 313-313, 2009. |
Examination - of the exercise therapy effect without examination - medication change of the exercise therapy effect on 1B-11 Parkinson disease Masahiro Konishi 1, Original one 2, Atsuko Imagawa 2, Yoshihiro Wakayama 3 Neurological Therapeutics 26(3): 314-314, 2009. |
Examination of the dopamine agonist internal use situation and the aging about the cardiac valve reflux of patients with 1B-12 Parkinson disease Kazuhisa Tsukamoto, Yutaka Nagayama, Masayuki Ueda, The Hamamoto truth, Tairo Katayama Neurological Therapeutics 26(3): 314-314, 2009. |
Is the aorta atheromatosis lesion related to 1B-13 Cryptogenic stroke? Noriko Matsumoto, Kenichiro Sakai, Nobuyuki Kaneko, Junnya Aoki, Takeshi Iwanaga, Yasuyuki Iguchi, Kazumi Kimura Neurological Therapeutics 26(3): 315-315, 2009. |
To predict red infarct of the 1B-14 middle cerebral artery territory? Araki lap, Yasuhiro Hasegawa, Keizo Yasui, Yusuke Fujioka, 眞野智生 Neurological Therapeutics 26(3): 315-315, 2009. |
It is the clinical feature of the cerebral infarction case with microbleeds with 1B-15 MRI, T2* emphasis image Masaki Ikeda 1, Masakuni Amari 2, Masamitsu Takatama 3, Koichi Okamoto 1 Neurological Therapeutics 26(3): 316-316, 2009. |
Relations of 1B-16 hypertension treatment, antithrombotic drug internal use and cerebral hemorrhage Tomohide Adachi, Chiaki Arakawa, Saori Moriya, Jun Goto, Makoto Takagi Neurological Therapeutics 26(3): 316-316, 2009. |
1B-17 antithrombotic drug internal use is an early death factor of supratentorial cerebral hemorrhage 山下眞史, Noriko Matsumoto, Masao Watanabe, Ken Shibasaki product, Yasuyuki Iguchi, Kazumi Kimura Neurological Therapeutics 26(3): 317-317, 2009. |
Alternatively, the depression in patients with cerebral hemorrhage is ARB? a calcium channel blocker for 1B-18 acute phase Masao Watanabe, Takeshi Iwanaga, Noriko Matsumoto, Ken Shibasaki product, Yasuyuki Iguchi, Kazumi Kimura Neurological Therapeutics 26(3): 317-317, 2009. |
1 case of the superficial siderosis in acknowledgment of the image findings that 1B-19 was rare Koichi Nomura 1, Masayuki Ueda 1, Yuichi Komaba 1, Takeshi Seta Expo 1, 2, Laboratory of Katsura Ichiro 1, Tairo Katayama 1 Neurological Therapeutics 26(3): 318-318, 2009. |
One case of the anterior spinal artery syndrome that presented 1B-20 Cervical angina, and occurred for both upper extremities paralysis Satoshi Nakae fine weather 1, Yoshiyuki Kuroiwa 2 Neurological Therapeutics 26(3): 318-318, 2009. |
One case of the venous sinus thromboses given percutaneous transluminal angioplasty with 1B-21 AT-3 low level 北惠詩穂里 1, 2 Neurological Therapeutics 26(3): 319-319, 2009. |
Clinical analysis of the 1B-22 antiphospholipid antibody association ischemic cerebrovascular disease 3 case that we were able to relatively follow up for a long term Jun Goto, Chiaki Arakawa, Midori Tanda, Junko Yoneta, Shinji Nokoshi, Tomohide Adachi, Makoto Takagi Neurological Therapeutics 26(3): 319-319, 2009. |
One case of the amaurosis fugax repeating 1B-23 attack frequently Yuko Kato 1, 中野智伸 2, Junichi Niwa 1, Yuka Enomoto 1, Fujikake Akifumi 1, Takashi Fukuoka daylight 1, Satoshi Goto five 1, Spring Masayuki 1, Naoki Nakao 1, 道勇学 1 Neurological Therapeutics 26(3): 320-320, 2009. |
Examination about clinical features of the 1B-24 transient global amnesia and the treatment Yutaka Suzuki, Tomohiko Mizutani Neurological Therapeutics 26(3): 320-320, 2009. |
Histories of treatment of the 1B-25 Reversible cerebral vasoconstriction syndrome3 case Hirotsugu Okamoto, Yue Inamori, Kenichi Ikeda, Osamu Watanabe, 有村公良 Neurological Therapeutics 26(3): 321-321, 2009. |
One case of myasthenia gravis that showed dissociation for 1C-01 blood anti-AChR antibody titers and the change of clinical manifestations Masaya Hashimoto 1, Masayuki Yoshioka 1, Maiko Murakami 1, Tadashi Kurita 2, Masahiko Suzuki 1 Neurological Therapeutics 26(3): 322-322, 2009. |
Examination about the potential occlusal force decrease in 1C-02 myasthenia gravis 保月隆良, Imai wealth, Emiko Tsuda, The Kuhara truth, 下濱俊 Neurological Therapeutics 26(3): 322-322, 2009. |
5 cases of aplasia pure red cells (PRCA) complicated for myasthenia gravis (MG), a thymoma in the 1C-03 our department Katsuya Sato 1, Taku Fukuda 1, Six storehouse Kazuo 1, 徳田昌紘 1, Yohei Tateishi 1, Sakai (Kayo) no 1, Futago, Measure field Tomoko 1, Akira Tsujino 1, Toshiaki Yoshimura 2, Ryu Nakamura sentence 3, Masakatsu Motomura 1, Katsumi Eguchi 1 Neurological Therapeutics 26(3): 323-323, 2009. |
Thymoma follow-up in 1C-04 patients with myasthenia gravis 菅原正伯 1, Chizuru Wada 1, 2, Toshima solstice 1, 2 Neurological Therapeutics 26(3): 323-323, 2009. |
53 years old woman case of myasthenia gravis that malignant thymoma recurred as chest wall adenophyma through 20 years or more from 1C-05 primary operation 吉沢和朗 1, 稲毛芳永 2, Akio Otani 3 Neurological Therapeutics 26(3): 324-324, 2009. |
Women with 77 years old case of myasthenia gravis that led to remission without a side effect with a low-dose steroid by early induction of 1C-06 Tacrolimus Yasuhiro Nagashima, Kazuhiro Muramatsu, Kute Kenji, Naoko Ogura, Michiyuki Maruyama, Country book Masaya Neurological Therapeutics 26(3): 324-324, 2009. |
Use of tacrolimus case of systemic type myasthenia gravis who had the 1C-07 pulmonary emphysema 有里敬代, Sonoda man of exceptional virtue, Yuichi Uchida, Kyoko Maruta, Hidetoshi Fukunaga Neurological Therapeutics 26(3): 325-325, 2009. |
It is examined 35 patients with myasthenia gravis using tacrolimus in 1C-08 our department Yuji Mizuno, Koichi Okamoto Neurological Therapeutics 26(3): 325-325, 2009. |
About the efficacy of the tacrolimus chronic administration (60 months) for 1C-09 myasthenia gravis (MG) South Naoya 1, Naoto Fujiki 1, Shizuka Doi tree 1, Seishi Kikuchi 1, Hidenao Sasaki 2, Isao Shima two 3 Neurological Therapeutics 26(3): 326-326, 2009. |
Use of ciclosporin experience of patients with myasthenia gravis in the 1C-10 this hospital Yuko Nemoto, Naoki Kawaguchi, Hirokazu Takahashi, Satoshi Kuwahara Neurological Therapeutics 26(3): 326-326, 2009. |
It is efficacy and the safety for two years ciclosporin microemulsion pre-concentrate(CsA MEPC) for 1C-11 myasthenia gravis (MG) Yuriko Nagane 1, Spear swamp New Komeito 1, Shigeaki Suzuki 2, Norihiro Suzuki 2 Neurological Therapeutics 26(3): 327-327, 2009. |
Efficacy of the intermittent immunoglobulin therapy in myasthenia gravis of 1C-12 elderly people Takashi Kurokawa 1, Hill housekeeping husband 1, Yoshiyuki Kuroiwa 2 Neurological Therapeutics 26(3): 327-327, 2009. |
1C-13 Impact factor to the drug blood concentration in myasthenia gravis calcineurin inhibitor treatment 川口直樹, 根本有子, 高橋宏和, 桑原聡 Neurological Therapeutics 26(3): 328-328, 2009. |
Attack disappearance rate for the treatment of 1C-14 elderly people onset epilepsy, examination of the treatment continuance rate Mitsuhiko Yamano, Naoki Akamatsu, 辻貞俊 Neurological Therapeutics 26(3): 328-328, 2009. |
Utility of the long time electroencephalographic recording in the 1C-15 epilepsy practice Masahiro Mizobuchi, Sako just one, Atsuko Nihei, Miho Idogawa Neurological Therapeutics 26(3): 329-329, 2009. |
One case that botulinum toxin was effective for platysmal bands which occurred all over the course of the 1C-16 hemifacial spasm Hisashi Ito, Toru Kamei plus Neurological Therapeutics 26(3): 329-329, 2009. |
1C-17 breast cancer women with 64 years old that caused periscapular muscular involuntary movement postoperatively, and responded to botulinum treatment Sonoko Misawa, Hayakawa province, Icehouse Keiichi, 澤井摂, Shoichi Ito, Satoshi Kuwahara Neurological Therapeutics 26(3): 330-330, 2009. |
One case of schizophrenia that presented rhabdomyolysis secondary to 1C-18 water intoxication, malignant syndrome Yohei Fujii, Aya Okuma, Yoshihiko Nakazato, 田村直俊, Nobuo Araki Neurological Therapeutics 26(3): 330-330, 2009. |
The 32 years old man case that a beta-blocker was effective for postural tachycardia syndrome (POTS) after the 1C-19 acute pandysautonomia Masato Asahina 1, Fujinuma Yoshikatsu 1, 山中義崇 1, 2, Akira Katagiri 1, Satoshi Kuwahara 1 Neurological Therapeutics 26(3): 331-331, 2009. |
One case of chilly induced excessive sweating treated effectively with 1C-20 Amitriptyline HCl Yoshihiko Nakazato, 田村直俊, Aya Okuma, Kimiko Yoshimaru, Mitsuru Ninomiya Yoshiko, Nobuo Araki Neurological Therapeutics 26(3): 331-331, 2009. |
One case of acromelalgia that the sympathetic nerve block in the 1C-21 Gabapentin, carbamazepine, vein was effective Daisuke Sato, Akio Yokozeki, 上村昌寛, 徳武孝允, 下畑享良, Masatoyo Nishizawa Neurological Therapeutics 26(3): 332-332, 2009. |
Restless legs syndrome in patients with 1C-22 diabetes Hitoshi Aizawa 1, Takayuki Katayama 1, Naoyuki Hasebe 1, Takashi Kimura 2, 箭原修 2 Neurological Therapeutics 26(3): 332-332, 2009. |
One case of the steroid-resistant hypertrophic cranial pachymeningitis treated effectively with 1C-23 Tacrolimus 中川道隆, Kodaira agriculture, Yukihiro Shimojima, Shuichi Ikeda Neurological Therapeutics 26(3): 333-333, 2009. |
Two cases of the idiopathic cranial hypertrophic pachymeningitis that 1C-24 Tacrolimus was effective, and cerebrospinal fluid IL-6 reflected condition Tomoaki Kameda 1, Jomura Yuji 2, Tatsuya Takahashi 2, Atsuko Tomita 1, Hiroshi Doi 1, Children Shigeru Yano 1, Suzuki dream 1, Yoshiyuki Kuroiwa 1 Neurological Therapeutics 26(3): 333-333, 2009. |
1C-25 rheumatoid factor and long-term course case of the MPO-ANCA-positive hypertrophic dura mater flame Kazuhiro Sanpei Neurological Therapeutics 26(3): 334-334, 2009. |
One case of Progressive Encephalomyelitis with Rigidity and Myoclonus which occurred for 1C-26 spinal cord-related myoclonus Yoshiaki Urano 1, 飯塚高浩, Sato hemp arch, Saori Miyakawa, Akutsu two husbands, Junichi Hamada, Fumihiko Sakai Neurological Therapeutics 26(3): 334-334, 2009. |
Examination of the clinical features of five patients with myopathy in acknowledgment of 1D-01 CK level 10,000IU/l or more and significant high level and the myopathy law of nature 長坂江理, Yukio Fujita, Natsumi Furuta, Shun Nagamine, Koichi Okamoto Neurological Therapeutics 26(3): 335-335, 2009. |
1 case of the myositis GVHD-related after the allogeneic peripheral blood stem cell transplantation that resulted in 1D-02 extensive respiratory muscle disorder Tadashi Kondo British 1, Koji Matsuo 1, Haruki Koike 1, Naoki Hattori 1, Sofue former 1, Tetsuya Nishida 2, Makoto Murata 2 Neurological Therapeutics 26(3): 335-335, 2009. |
About a polymyositis 2 case of the 1D-03 steroid resistance Yokoi profound knowledge, Eiichiro Mukai, Satoshi Okuda, Rei Kobayashi Neurological Therapeutics 26(3): 336-336, 2009. |
Development (the second report) of the muscular dystrophy therapy with the 1D-04 transforming growth factor-beta type I serine threonine kinase receptor inhibitor Yutaka Osawa, Atsushi Kuga, Saori Hayashi, Rikimaru Mitsue, Ryu Murakami sentence, Yoshihide Sunada Neurological Therapeutics 26(3): 336-336, 2009. |
Examination of plasminogen activating system in the muscle process of regeneration of the 1D-05 Cardiotoxin injury model mouse 村田顕也, Hideto Miwa, Tomoyoshi Kondo Neurological Therapeutics 26(3): 337-337, 2009. |
The respiratory function analysis of the 1D-06 muscular dystrophy model mouse and respiratory function improvement by the entire length dystrophin induction to diaphragm Masatoshi Ishizaki 1, Akiko Kawano, Kan Tomohiro, Madoka Kimura, Yasushi Maeda, Makoto Uchino Neurological Therapeutics 26(3): 337-337, 2009. |
Duchenne muscular dystrophy gene therapy study using 1D-07 Lentiviral vector Kan Tomohiro 1, Madoka Kimura 1, Katsuhisa Uchino 1, Tatsuya Koide 1, Masatoshi Ishizaki 1, Tetsuo Sakamoto 1, Tomoji Uchida 2, Masaru Yamashita 1, Yasushi Maeda 1, Makoto Uchino 1 Neurological Therapeutics 26(3): 338-338, 2009. |
Skeletal muscle reproduction with 1D-08 gene, the stem cells treatment and treatment study of muscular dystrophy Madoka Kimura 1, 2, Kan Tomohiro 1, Katsuhisa Uchino 1, Tatsuya Koide 1, Jay J Han2, 3, Sheng Li2, Tomoji Uchida 1, 4, Masaru Yamashita 1, Yasushi Maeda 1, Jeffrey S.Chamberlain2, Makoto Uchino 1 Neurological Therapeutics 26(3): 338-338, 2009. |
Genetic manipulation by the viral vector to mesenchymal stem cells derived from a marrow framework toward the 1D-09 muscular dystrophy origin treatment Yasushi Maeda, Masatoshi Ishizaki, Madoka Kimura, Makoto Uchino Neurological Therapeutics 26(3): 339-339, 2009. |
Examination of the clinical picture of five myotonic dystrophy of the 1D-10 progress period Mayumi Murata, Takahiro Toda, Shingo Konno, Hollow Hiroshi, 野本信篤, Hideki Sugimoto, Hiroshi Nemoto, Toshiki Fujioka Neurological Therapeutics 26(3): 339-339, 2009. |
One case of the Stiff-person syndrome which maintained remission by 1D-11 immune adsorption therapy Kanako Shimizu 1, 白石眞 1, 徳山承明 1, Toshiyuki Yanagisawa 1, Country incense Naoya 1, Toshikazu Hirayama 1, Masahiko Tanizawa 2, Yasuhiro Hasegawa 1 Neurological Therapeutics 26(3): 340-340, 2009. |
Trial of the rituximab treatment for the 1D-12 Stiff-person syndrome Kato Shumei, Koichi Tazawa, Wataru Ishii, Hiroshi Morita, Masayuki Matsuda, Shuichi Ikeda Neurological Therapeutics 26(3): 340-340, 2009. |
It is tried the rituximab administration for dystonia of the 1D-13 SLE Yuko Kawamura Neurological Therapeutics 26(3): 341-341, 2009. |
Involuntary movement of toes with hyperthyroidism improved by 1D-14 antithyroid remarkably Makoto Nomura, Seiichi Ono Neurological Therapeutics 26(3): 341-341, 2009. |
Two cases of encephalopathy due to the 1D-15 thyrotoxic crisis 浦茂久, Ikuko Takahashi, Jin Nakano, The laboratory of Kuroshima beauty, Kazuto Yoshida Neurological Therapeutics 26(3): 342-342, 2009. |
One patient who 1D-16 Chronic Acquired Hepatocerebral Degeneration(CAHD) developed, and responded to branched-chain amino acid (BAA) 土肥栄祐, Kazuhide Ochi, Yuki Nakata, Yoshio Matsuda, Yamasaki male, Tsuyoshi Nakamura, Tatsuo Kooriyama, Masayasu Matsumoto Neurological Therapeutics 26(3): 342-342, 2009. |
Examination of the effect of the Idursulfase (genetic recombination) treatment on adolescents men of the 1D-17 inborn character-related mucopolysaccharide dysbolism type 2 Sakamoto light, Ikuko Yamada, Nakamura male product Neurological Therapeutics 26(3): 343-343, 2009. |
Establishment of the high-throughput screening using the SELDI-TOF MS for the 1D-18 FAP early treatment Mitsuharu Ueda 1, Yohei Misumi 2, Taro Yamashita 2, Great Hikaru Hayashi sense 1, Hiroshi Kino 1, Makoto Uchino 2, Yuki Ando male 1 Neurological Therapeutics 26(3): 343-343, 2009. |
Efficacy of diet and sodium pyruvate in the 1D-19 adult type citrullinemia (CTLN2) patients Masahide Yazaki 1, Shuichi Ikeda 1, Keiko Kobayashi 2, Takeyori Saeki 3 Neurological Therapeutics 26(3): 344-344, 2009. |
One case of diabetic amyotrophy that responded to 1D-20 intravenous immune globulin therapy Kaori Itokawa 1, Fukui Sea tree 1, Kazuki Ono 1, Tatsuya Abe 1, Toshimasa Yamamoto 1, Akira Iwasaki 2, Tetsuo Komori 1, 田村直俊 1, Nobuo Araki 1 Neurological Therapeutics 26(3): 344-344, 2009. |
Examination of the therapy for slowly-progressive amyotrophic muscle weakness of bilateral feet found in 1D-21 diabetes Hiroaki Ishikawa, Hirotsugu Mikami, Makoto Nomura, Jin Suzuki, Seiichi Ono Neurological Therapeutics 26(3): 345-345, 2009. |
Examination of the recurrence prevention effect of a little steroid continuous medication for the 1D-22 antiaquaporin-4 antibody positive case Yoshiharu Taguchi 1, Takashima Shutaro 1, Shigeo Toyota 1, Tool Shinko 1, Koji Hirano 1, Nukui Takamasa 1, Kotaro Tanaka 1, Keiko Tanaka 2 Neurological Therapeutics 26(3): 345-345, 2009. |
Two cases of Neuromyelitis optica where the combination of 1D-23 steroid-pulse therapy and immunoglobulin bolus dose was effective Hideo Terasawa, Hiromasa Toji, Toshi Kataoka Neurological Therapeutics 26(3): 346-346, 2009. |
One case of the multiple sclerosis that 1D-24 IFN beta therapy unresponsiveness produced a wide range of bilateral frontal lobe inside lesions and introduced cyclophosphamide pulse therapy into Nozomi Matsuda 1, Megumi Yasuda 1, Straight tea bowl Teiko 1, Hitoshi Mochizuki 1, Tomohiro Kumagai 1, Mutsuko Sato 2, Yoshikazu Ugawa 1 Neurological Therapeutics 26(3): 346-346, 2009. |
1D-25 3 cases of anti-aquaporin-4 antibody-positive using IFNβ1b 佐藤滋1, 藤原一男2, 3, 中島一郎2, 高橋利幸2, 4, 糸山泰人2 Neurological Therapeutics 26(3): 347-347, 2009. |
1 case that cerebral infarction developed at 1D-26 multiple sclerosis relapse, and racked its brains about a diagnosis and treatment Masanobu Mizuno 1, Kanako Konno 1, 深浦彦彰 1, Hisashi Yonezawa 1, Yasuo Terayama 1, Hirotaka Oikawa 2 Neurological Therapeutics 26(3): 347-347, 2009. |
Two cases of the acute cerebellitis that 1E-01 immune adsorption therapy was effective Takeshi Yamada Neurological Therapeutics 26(3): 348-348, 2009. |
Effect of treatment of IVIg for the 1E-02 Bickerstaff type brainstem encephalitis 保前英希, Masakazu Nakamura Neurological Therapeutics 26(3): 348-348, 2009. |
22 years old woman case of ovarian teratoma merger encephalitis that there were no 1E-03 involuntary movement, hypoventilation in Masanori Sakamaki, Kazuhisa Tsukamoto, Yutaka Nagayama, Hideko Sunami, Mineo Yamazaki, Tairo Katayama Neurological Therapeutics 26(3): 349-349, 2009. |
One case of teratoma-related encephalitis with the antiglutamate receptor antibody which was resistant to a lot of 1E-04 treatment Makoto Eriguchi 1, 2, Emi Tabata 1, Saori Mitsutake 1, Nanri Yusuke 1, Osoegawa studies 1, Yusuke Yakushiji 1, Tatsu Okada Ichiro 1, Snow bamboo Motohiro 1 Neurological Therapeutics 26(3): 349-349, 2009. |
One case that steroid-pulse therapy was effective for limbic encephalitis due to 1E-05 Hodgkin disease 豊田元哉, Shuhei Yamaguchi, 卜蔵浩和, Hiroaki Oguro Neurological Therapeutics 26(3): 350-350, 2009. |
76 years old man case of the paraneoplastic limbic encephalitis due to 1E-06 thyroid cancer Nagasaka Takamura, The history of Kobayashi sum, Haruyasu Iida, Rieko Kobayashi, Kaori Nagasaka, Shindo Yorimasa, Yoshihisa Takiyama Neurological Therapeutics 26(3): 350-350, 2009. |
One case of the voltage-gated potassium channel antibodies-positive limbic encephalitis that a 1E-07 unification dystonia-like symptom was a cardinal symptom Yuichi Hayashi, Akira Kimura husband, Megumi Yamada, Takeo Sakurai, Yuji Tanaka 1, 保住功, Takashi Inuzuka Neurological Therapeutics 26(3): 351-351, 2009. |
One case of antiNAE antibody-negative Hashimoto encephalopathy which presented SPECT findings of the Alzheimer type dementia resemblance in the early period of 1E-08 Yuichi Hayashi, Akira Kimura husband, Megumi Yamada, Takeo Sakurai, Yuji Tanaka, 保住功, Takashi Inuzuka Neurological Therapeutics 26(3): 351-351, 2009. |
One case of antiGAD antibody-positive encephalopathy improved by plasmapheresis in acknowledgment of a wide range of lesions by 1E-09 head MRI remarkably Yuko Koga, Takahisa Tateishi, 河村信利, Doi light, Ishizu Akira Shou, 大八木保政, Junichi Kira Neurological Therapeutics 26(3): 352-352, 2009. |
1E-10 The enzyme replacement therapy for Fabry disease patients who repeated cerebral infarction : Course of agalsidase beta use 5 years 米澤久司1, 川守田厚2, 大塚千久美1, 寺山靖夫1 Neurological Therapeutics 26(3): 352-352, 2009. |
Histories of treatment of the enzyme supplemementary therapy in three 1E-11 Fabry's disease Kazuhiro Horiuchi, Yukiko Akimoto, Xinye Masaaki, Ichiro Yabe, Hidenao Sasaki Neurological Therapeutics 26(3): 353-353, 2009. |
Objective muscular strength evaluation for the enzyme supplemementary therapy in 1E-12 adult type Pompe disease Rei Isayama name, Shiga Kensuke, Kuriyama Nagato, 武澤信夫, Nakagawa teachings of Buddha Neurological Therapeutics 26(3): 353-353, 2009. |
Likelihood of the IVIg therapy in the CMTX case with the 1E-13 GJB1 deletion Sakaguchi Shuya 1, Masaru Yamashita 1, Tomoo Hirahara 1, Madoka Kimura 1, Yasushi Maeda 1, Shuji Terasaki 2, Teruyuki Hirano 1, Makoto Uchino 1 Neurological Therapeutics 26(3): 354-354, 2009. |
One case of the Isaacs syndrome of the senile-onset improved for iteration of the 1E-14 immunotherapy Shimatani Kei light, Yoshiko Kawahata, Private temple Hiroyuki, Izumi mere sincerity, 梶龍兒 Neurological Therapeutics 26(3): 354-354, 2009. |
The 59 years old woman case that the sarcoid neuropathy that presented 1E-15 motor nerve conduction block was treated effectively with an IVIG Kawano A, Takayuki Saito, Shusaku Omoto, 仙石錬平, Hiroshi Taniguchi, 持尾聰一郎 Neurological Therapeutics 26(3): 355-355, 2009. |
Comparison of the episode of care in the 1E-16 Churg Strauss syndrome 2 case Yuichi Uchida, Sonoda man of exceptional virtue, Kyoko Maruta, 有里敬代, Hidetoshi Fukunaga Neurological Therapeutics 26(3): 355-355, 2009. |
One case of the polyarteritis nodosa that assumed 1E-17 intermittent claudication chief complaint, and was treated effectively with a steroid Shirafuji law way, Tadanori Hamano, 中地亮, Tomoko Muramatsu, 岸谷融, Asako Ueno, Akihiro Fujii, Osamu Yamamura, Makoto Yoneta, 栗山勝 Neurological Therapeutics 26(3): 356-356, 2009. |
Association between 1E-18 cerebral white matter lesion and carotid echo and carotid estimate blood pressure Yuko Niijima 1, 竹川英宏 1, Hideaki Tanaka 2, Koichi Hirata 2 Neurological Therapeutics 26(3): 356-356, 2009. |
One case that CAA-related inflammation was suspected in 1E-19 brain MRI, and steroid therapy was effective Yuichiro Ii 1, Ryo Sasaki former 1, Hatazaki Seiji 2, Tomimoto Hidekazu 1 Neurological Therapeutics 26(3): 357-357, 2009. |
A comparison of the substance P by the presence or absence of basal ganglia lesion in 1E-20 chronic stage cerebral infarction and change by nicergoline Yasuhiro Nishiyama, Masayuki Ueda, Yutaka Nagayama, Tairo Katayama Neurological Therapeutics 26(3): 357-357, 2009. |
Effect of simvastatin on blood asymmetric dimethylarginine in 1E-21 chronic stage inpatients 櫻澤誠 1, 2, Yasuhiro Nishiyama 1, Yuichi Komaba 1, Laboratory of Katsura Ichiro 1, Tairo Katayama 1 Neurological Therapeutics 26(3): 358-358, 2009. |
After 1E-22 cerebral infarction about a clinical response with the fluvoxixamine administration for the patients of the depressive state examination - second report - Hideko Sunami, Kazuhiro Usuda, Tairo Katayama Neurological Therapeutics 26(3): 358-358, 2009. |
Utility of the neurologic music therapy for the gait disturbance due to the 1E-23 thalamus injury Abiru Mutsumi 1, Chizuru Nakano 1, Yutaka Kikuchi 1, Mihara Yoshiko 1, Mikio Fujimoto 1, Beautiful master 1 Neurological Therapeutics 26(3): 359-359, 2009. |
1E-24 SOD1overexpression relieves a blood-brain barrier disorder after the ischemic reperfusion by inhibiting p38MAPK/cPLA2 pathway Chikako Nito, Masayuki Ueda, Tairo Katayama Neurological Therapeutics 26(3): 359-359, 2009. |
Cerebroprotection effect of the EPA-E premedication in the 1E-25 rat transient local cerebral ischaemia model Masayuki Ueda, Satoshi Suda, Nobuo Kamiya, Yasuhiro Nishiyama, Seiji Okubo, Chikako Nagata, Yutaka Nagayama, Tairo Katayama 1 Neurological Therapeutics 26(3): 360-360, 2009. |
Study on economical self-pay of 2A-01 amyotrophic lateral sclerosis Tomohisa Uchida, 相澤勝健, Masaki Takao, Beautiful master Neurological Therapeutics 26(3): 361-361, 2009. |
Dissociated significance of estimation glomerular filtration rate (eGFR) of serum cystatin C (CysC) in the 2A-02 ALS and the serum creatinine (Cr) Shuichi Tezuka, Yuko Nakamura, Mikio Sawada, Mitsuya Morita, Tadataka Kawakami, Kunihiko Ikeguchi, Imaharu Nakano Neurological Therapeutics 26(3): 361-361, 2009. |
The 2A-03 Metallothionein instruction inhibits the motoneuron death of the amyotrophic lateral sclerosis mouse and improves an ALS-like symptom Eiichi Tokuda 1, 2, Shunsuke Watanabe 1, Eri Okawa child 1, Takashi Suzuki 1, Kazuo Uchikura 1, Shinichi Ono 1, 3, 4 Neurological Therapeutics 26(3): 362-362, 2009. |
Free radical scavenger, effect of edaravon on 2A-04 ALS rat Masashi Aoki 1, Wariden kernel 1, Hideki Mizuno 1, Naoteru Suzuki 1, 幸敏志 2, Ikuo Takahashi 3, Yasuto Itoyama 1 Neurological Therapeutics 26(3): 362-362, 2009. |
leuprorelin acetate therapy for the familial ALS with 2A-05 SOD1 gene L126S mutation Yoshiki Adachi, Descent from a mountain Ryoji Neurological Therapeutics 26(3): 363-363, 2009. |
Investigational characteristics and problems for the 2A-06 neurodegenerative disease from investigational experience for amyotrophic lateral sclerosis: Katsuhisa Ogata 1, 2, Mikiya Suzuki 1, Mitsuru Kawai 1 Neurological Therapeutics 26(3): 363-363, 2009. |
triptan treatment to patients with migraine headache that 2A-07 analgesic is effective Kenji Takagi, Kaoru Yamazaki, Mio Arai, Itsu Nojima, Ei Kobayashi kernel Neurological Therapeutics 26(3): 364-364, 2009. |
Effective and safe examination of the 2A-08 analgesic-resistant children, triptan preparation for the pubertal migraine headache Shigekazu Kitamura 1, Yoshihisa Tateoka 2 Neurological Therapeutics 26(3): 364-364, 2009. |
Examination of the migraine headache case that consulted a headache outpatient of the 2A-09 this hospital Hattori lawn seedling, Hisashi Ito, Shun Asakawa, Toru Kamei plus Neurological Therapeutics 26(3): 365-365, 2009. |
Examination of the migraine headache preventive therapy in the 2A-10 headache outpatient department Market price Ayako, Person from dragon former sect, 斎須章浩, Kazuhito Kimoto, Koichi Hirata Neurological Therapeutics 26(3): 365-365, 2009. |
Analysis of the substance abuse headache 66 case in the 2A-11 Tottori University headache outpatient department Koichi Suenaga 1, 2, Takeshima Taga husband 1, Kenji Sakuma 1, Shigeko Imamura 1, Bunch cheap Emi 1, 3, Kenji Nakajima 1 Neurological Therapeutics 26(3): 366-366, 2009. |
Stroke patients dynamics - Tama stroke meeting for the study report first report - in the 2A-12 Tama, Tokyo district Kazunari Honma, Takashi Yasuda, 大貫知英, Kentaro Tokuoka, Yasuhisa Kitagawa Neurological Therapeutics 26(3): 366-366, 2009. |
Comparison of the discharge ADL before and after the stroke regional alliances pass induction in patients with 2A-13 cerebral infarction 野々山忠芳 1, Osamu Yamamura 2, Masashi Kubota 1, Yasutaka Kobayashi 3, Fukuzumi season 4, Seiichiro Shimada 1, Shinichi Sasaki 1, Hisatoshi Baba 1, 栗山勝 2 Neurological Therapeutics 26(3): 367-367, 2009. |
The at-home discharge of patients with 2A-14 acute ischemic stroke and relations of Berg Balance Scale Masashi Kubota 1, Osamu Yamamura 2, 野々山忠芳 1, Shinichi Sasaki 1, Seiichiro Shimada 1, Hisatoshi Baba 1, 栗山勝 2 Neurological Therapeutics 26(3): 367-367, 2009. |
Initial treatment results of the CAS for the 2A-15 CEA high risk case Sei Watanabe tree, Makoto Nakajima, Teruyuki Hirano, Makoto Uchino Neurological Therapeutics 26(3): 368-368, 2009. |
In recognition investigation III- multiphasic health screening testee of the t-PA intravenous-injection treatment of the 2A-16 citizen - Kuniyasu Wada 1, Yasuyuki Hara 1, Shuji Terasaki 1, 東大弼 2, Circle Tetsu Hayashi 3, Teruyuki Hirano 4, Makoto Uchino 4 Neurological Therapeutics 26(3): 368-368, 2009. |
Altitudinal hemianopsia occurs in neuromyelitis optica examination of the visual field disturbance due to the optic neuritis in 2B-01 neuromyelitis optica and the multiple sclerosis Takashi Hosokawa 1, Hideto Nakajima 2, 土居芳充 1, Shoichi Sugino 1, Bunji Kimura 1, Toshiaki Hanabusa 1, Toshiyuki Takahashi 3 Neurological Therapeutics 26(3): 369-369, 2009. |
2B-02 One example of a large number of brain lesion recurrence was observed multiple sclerosis AQP4 antibody-positive immediately after discontinuation of Interferonβ1b (IFN) 佐藤俊一1, 吉田拓弘1, 星研一1, 矢彦沢裕之1, 田中惠子2 Neurological Therapeutics 26(3): 369-369, 2009. |
Clinical conference of 2 cases that did not meet the diagnostic criteria of Neuromyelitis optica(NMO) with 2B-03 antiAQP4 antibody positive Field Chihiro child, Hideki Takubo, Masayuki Yokochi Neurological Therapeutics 26(3): 370-370, 2009. |
Is the 2B-04 double membrane filtration concentration method effective for the treatment to a recurrence of the multiple sclerosis? Masami Tanaka 1, Emiko Muramoto 1, Miki Ono 1, 2, Eiko Murase 1, Keiko Tanaka 2, Tetsuro Konishi 1 Neurological Therapeutics 26(3): 370-370, 2009. |
Examination of the simple plasma exchange in 2B-05 NMO Toshiyuki Takahashi 1, Ichiro Nakajima 2, Kazuo Fujiwara 2, Yasuto Itoyama 2 Neurological Therapeutics 26(3): 371-371, 2009. |
Blood purification therapy for the 2B-06 NMO prevention of recurrence Shoichi Miyamoto 1, Masami Ueda 1, Ikuko Yamada 2, Nakamura male product 2, 楠進 1 Neurological Therapeutics 26(3): 371-371, 2009. |
Amyotrophic lateral sclerosis (ALS) that exacerbation of hyperlipidemia was detected at the 2B-07 onset, and progressed with the improvement rapidly Masato Tamura, Akira Shinpo, Elisa Shikata, Toshiaki Takasu, Mai Yamaguchi, Jun Takeshita, Yo Sugano, Kenji Miki, Teruyuki Takahashi Neurological Therapeutics 26(3): 372-372, 2009. |
One case that was effective for patients with amyotrophic lateral sclerosis that 2B-08 Clarithromycin single administration repeated pneumonia frequently Kenji Yamaoka 1, Hiroshi Shiota 2, Tomohiro Furuichi 1 Neurological Therapeutics 26(3): 372-372, 2009. |
Characteristic of respirator wearing amyotrophic lateral sclerosis who had 2B-09 pneumothorax 駒井清暢 1, 田上敦朗 2, Kazuya Takahashi 1, Chiho Ishida 1 Neurological Therapeutics 26(3): 373-373, 2009. |
About a utility of the helmet type mask in NPPV of the 2B-10 ALS case Yutaka Hagino 1, Mieko Hagino 2, It is merely 3 in a river, Shinichi Uryu 4, Junichi Hamada 2, Fumihiko Sakai 2 Neurological Therapeutics 26(3): 373-373, 2009. |
About "the moratorium effect" that noninvasive positive pressure ventilation therapy results in to patients with 2B-11 amyotrophic lateral sclerosis Rei Kurisaki one 1, Junko Suzuki 2, Maruyoshi summer British 1, 植川和利 1, Makoto Uchino 2 Neurological Therapeutics 26(3): 374-374, 2009. |
One case of amyotrophic lateral sclerosis that the walk durability improved by 2B-12 harness therapy Yutaka Kikuchi 1, 阿部百合恵 2, Fusae Imaizumi 2, Yoko Takahashi 2, Masaki Takao 4, Beautiful master 3 Neurological Therapeutics 26(3): 374-374, 2009. |
Nutritional management and vital prognosis in patients with 2B-13 ALS Makiko Nagai, Kentaro Deguchi, Excellent Shoko Furuya, Table Yoshio, Tetsuya Nagata, Ikeda Kei life, Koji Abe Neurological Therapeutics 26(3): 375-375, 2009. |
Two patients who responded to gabapentin for pain with 2B-14 amyotrophic lateral sclerosis West Shinsuke, Hideshi Ueyama, Nishida leading figure, Now Hiroshi Murashige Neurological Therapeutics 26(3): 375-375, 2009. |
About the morphine HCl continuation subcutaneous injection with the pane blocker pump in patients with 2B-15 at-home ALS Eiji Kitamura 1, Mieko Ogino 1, Naoki Doi 2, Junichi Hamada 1, Fumihiko Sakai 1 Neurological Therapeutics 26(3): 376-376, 2009. |
Comparison when we reminded a student of 2B-16 SF-36 and a feeling of mental burden ALS example at the SEIQoL-DW answer Narita Yugo 1, 2 Neurological Therapeutics 26(3): 376-376, 2009. |
Examination of the mild brain hypothermia therapy for the 2C-01 acute ischemic stroke Arabian bird Tatsuo 1, Yasuhiro Nishiyama 1, Seiji Okubo 1, Mizukoshi spirit 2, Long Tomoko Mine 1, Shunsuke Kobayashi 1, Miwako Ohashi 1, Ayako Tsuchiya 1, Yuichi Komaba 1, Laboratory of Katsura Ichiro 1, Tairo Katayama 1 Neurological Therapeutics 26(3): 377-377, 2009. |
Relations of prognosis and CHADS2 score of the cardiogenic cerebral embolism due to the 2C-02 non-valvular atrial fibrillation Fumio Yamamoto 1, It is still 1 light wisteria, Yasuyuki Ito 1, Teruyuki Hirano 2, Yoichiro Hashimoto 2, Makoto Uchino 2 Neurological Therapeutics 26(3): 377-377, 2009. |
Difference of heart archencephalon embolism and cerebral thrombosis due to the paroxysmal atrial fibrillation judging from 2C-03 onset pattern 竹川英宏 1, Yuko Niijima 1, Tomohiro Ogawa 1, Yasushi Daimon 1, Kotobuki, Atsuko Ehata 1, Hideaki Tanaka 2, Koichi Hirata 2 Neurological Therapeutics 26(3): 378-378, 2009. |
About the preoperative coagulation management of the cerebral infarction 2 case that occurred in 2C-04 heart myxomas cellular embolus Tsuyoshi Uesugi 1, North Fumiko 1, Toshiya Takizawa 1, Shigeji Takagi 1, Shinichiro Shimura 2, Toshihiko Ueda 2 Neurological Therapeutics 26(3): 378-378, 2009. |
How is the malignant tumor treated after the cerebral infarction onset cerebral infarction with the 2C-05 malignant tumor? Haruyuki Hiraga, 鵜沢顕之, Ayako Tanaka, Kazue Ogawara, Boss Ikuo Neurological Therapeutics 26(3): 379-379, 2009. |
One case that we presented with significant cerebral circulatory failure with hypertriglyceridemia during 2C-06 prostate cancer treatment, and LDL adsorption therapy was effective Wataru Hara 1, Akihiro Kubota 1, Miki Kojima 1, Norifumi Yoshida 1, 王子聡 1, 山里将瑞 1, Misato Takahama 1, Tomoya Ogawa 1, 2, Osamu Matsumura 2, Kyoichi Nomura 1 Neurological Therapeutics 26(3): 379-379, 2009. |
A diagnosis and treatment (followup) of 2C-07 subacute necrotizing myelitis Shinsuke Hamada 1, Middle unofficial chronicles person 1, Sanae Honma 1, Asako Takei 1, Keiko Hamada 1, Kunio Tashiro 1, Tsuyoshi Hamada 1, Shunsuke Yano 2, Minoru Akino 2, 牛越聡 3, Hida single benefit 4 Neurological Therapeutics 26(3): 380-380, 2009. |
Pathomorphologic background of cerebrovascular disorder in 2C-08 CADASIL Akihiko Ueda 1, Teruyuki Hirano 1, Naoko Udaka 2, Keikichi Takahashi 3, Eiichiro Uyama 1, Makoto Uchino 1 Neurological Therapeutics 26(3): 380-380, 2009. |
Examination of the efficacy of the lomerizine HCl for 2C-09 CADASIL Noriko Ishigami 1, Toshiki Mizuno 1, Akiko Hosomi 1, Rei Isayama name 1, 永金義成 1, Masaki Kondo 1, Takao Kubota 2, Satoshi Okuyama cord 2, Takahiko Tokuda 1, Nakagawa teachings of Buddha 1 Neurological Therapeutics 26(3): 381-381, 2009. |
About the treatment of 2C-10 family characteristics high lipoprotein (a) blood disease 2 families Nobuo Sanjo 1, 2, Satoshi Ota 1, 水澤英洋 2 Neurological Therapeutics 26(3): 381-381, 2009. |
It is the examination in patients with hypertension a change of the cerebral blood stream volume by 2C-11 Olmesartan medoxomil 永田梨耶, Ken Ikeda, Seiichi Kawabe, 岩本康之介, 伊藤裕乃, Yuji Kawase, Kiyoko Murata, Rev. Sekine world, Takashi Takasawa period, Ryuta Sato, The Takashi Nakamura sum, Yuichi Ishikawa, Takeshi Miura, Yasuo Iwasaki Neurological Therapeutics 26(3): 382-382, 2009. |
One case of prime of life onset hereditary motor sensory neuropathy (HMSN)1a which we followed up by 2C-12 vitamin C bolus dose therapy for two years Narumi Nagayama, Kakiuchi no one, Keiko Tanaka, The Matsui truth Neurological Therapeutics 26(3): 382-382, 2009. |
Examination of the 2C-13 hyperplasia type CIDP one's own experiments case that presented various nerve findings, and showed significant cauda equina hyperplasia Masashi Tsujimoto, Koji Matsuo, Masahiro Iijima, Haruki Koike, Naoki Hattori, Origin of Sofue Neurological Therapeutics 26(3): 383-383, 2009. |
One case of refractory recurrent CIDP where 2C-14 Methotrexate was effective 斎須章浩, Person from dragon former sect, Market price Ayako, Ryotaro Takashima, Yuka Watanabe, Takahide Nagashima, Small hawk Masaaki, Koichi Hirata Neurological Therapeutics 26(3): 383-383, 2009. |
A diagnosis and treatment reversibility of the 2C-15 IGT neuropathy Great Hikaru Hayashi sense 1, Mitsuharu Ueda 1, Yohei Misumi 2, Hiroshi Kino 1, Yuki Ando male 1 Neurological Therapeutics 26(3): 384-384, 2009. |
One case of the n-Hexane neuropathy that showed a 2C-16 central nerve disorder about a process of the recovery by the exposure evasion: Jun Hashizume, Kawagashira Yuichi, 伊藤瑞規, Haruki Koike, 渡邉宏久, Naoki Hattori, Akira Tanaka view, Origin of Sofue Neurological Therapeutics 26(3): 384-384, 2009. |
2C-17 Colin drugs donepezil, propiverine combination therapy for the urination quality of life improvement of patients with dementia: Takatsugu Sakakibara 1, Tsuyoshi Ogata 2, Masahiko Kishi 1, Megumi Ogawa Mina 1, Tomoyuki Uchiyama 3, Tatsuya Yamamoto 3 Neurological Therapeutics 26(3): 385-385, 2009. |
45 years old woman case of the Perry syndrome where tandospiron citrate was effective for 2C-18 nucleus-related hypoventilation Yoko Kashimura, Masatoshi Omoto, Junichi Ogasawara, Kawai former fine weather, Kiyoshi Negoro, Takashi Kanda Neurological Therapeutics 26(3): 385-385, 2009. |
baclofen continuation intraspinal injection therapy for the 2C-19 spastic paraplegia Yutaka Naito, Morning Nichiri, Tomimoto Hidekazu Neurological Therapeutics 26(3): 386-386, 2009. |
One case of Lewy corpuscle type dementia that Kamikihito was effective for mental neurologic symptoms such as 2C-20 visual hallucination, delusions, the excitement Well hilum connection Neurological Therapeutics 26(3): 386-386, 2009. |
Utility of valproate Na and the donepezil HCl combination therapy to peripheral symptom of 2C-21 dementia Noriyuki Matsukawa, Yukio Kojika Neurological Therapeutics 26(3): 387-387, 2009. |
One patient who presented with multiple cerebral white matter lesions after 2C-22 herpes simplex encephalitis Island Sayuri, Miki Ueda, 上田真努香, Akihiro Ueda, 三原貴照, Kunihiko Asakura, Hideo Hara, 武藤多津郎 Neurological Therapeutics 26(3): 387-387, 2009. |
Two cases of bacterial meningitis who had the 2C-23 suppuration-related body of vertebra flame Kazuyuki Mizushima, Yasuo Harigai Neurological Therapeutics 26(3): 388-388, 2009. |
Examination of Hashimoto encephalopathy with the 2C-24 Creutzfeldt-Jakob disease-like clinical picture Tomoko Muramatsu 1, Makoto Yoneta 1, Akiko Matsunaga 1, Masamichi Igawa 1, Hiromi Yokoyama 1, Akihiro Fujii 1, Tadanori Hamano 1, Yoshio Matsuda 2, Kazuhiro Takamatsu 2, Takeo Sakurai 3, Takashi Inuzuka 3, 栗山勝 1 Neurological Therapeutics 26(3): 388-388, 2009. |
One case of Hashimoto encephalopathy that repeated a recurrence after 2C-25 spontaneous remission 高木伸之介 1, Yasuhiro Hijikata 2, Tetsuro Ando 2, 渡辺宏久 1, Naoki Hattori 1, Sofue former 1 Neurological Therapeutics 26(3): 389-389, 2009. |
Mainly on the infection that presented with prognosis - frequent occurrence cranial nerve injury of the base of skull lesion which performed start of therapy with 2C-26 cause being unknown 松村晃寛, Daisuke Yamamoto, Takanobu Toyoshima, Hideichiro Suzuki, Emiko Tsuda, Rika Yamauchi, 保月隆良, Takashi Hayashi, The Kuhara truth, Imai wealth, 下濱俊 Neurological Therapeutics 26(3): 389-389, 2009. |
Efficacy of the magnesium sulfate large quantities intravenous-injection treatment for the treatment of two 2C-27 severe tetanic - tetanus Ryuhei Yamada, Kohei Marumoto, Relation lower Mayumi, Keiji Matsumoto, Kageyama Takafumi, 2, Katsura, Ichikawa Neurological Therapeutics 26(3): 390-390, 2009. |
One case of the Satoyoshi illness that 2C-28 Methotrexate therapy was successful, and was able to chase course with small intestine capsule endoscope Shoko Tokunaga, Hirotsugu Okamoto, Yue Inamori, Kenichi Ikeda, Osamu Watanabe, 有村公良 Neurological Therapeutics 26(3): 390-390, 2009. |
One case of the adult Still illness that occurred for 2C-29 meningoencephalitis Akira Taniguchi 1, Ryo Sasaki former 1, Hiroshi Miyachi British 2, Norihiko Yamamoto 2, Tomimoto Hidekazu 1 Neurological Therapeutics 26(3): 391-391, 2009. |
Two cases of cluster headaches that showed the course that 2D-01 was interesting Shun Asakawa, Hisashi Ito, Hattori lawn seedling, Toru Kamei plus Neurological Therapeutics 26(3): 392-392, 2009. |
Three cases of cluster headaches that 2D-02 Sumatriptan at-home self-administration was effective Kazuhiro Muramatsu, Yasuhiro Nagashima, Kute Kenji, Naoko Ogura, Michiyuki Maruyama, Country book Masaya Neurological Therapeutics 26(3): 392-392, 2009. |
2D-03 One cases of idiopathic headache hypertension symptoms were improved by lumbar peritoneal shunt presents a headache and blurred vision 小川克彦1, 亀井聡1, 水谷智彦2 Neurological Therapeutics 26(3): 393-393, 2009. |
One case of the cerebrospinal fluid hypovolemia complicated with 2D-04 substance abuse-related headache It is still 1 light wisteria, Fumio Yamamoto 1, Yasuyuki Ito 1, Yasuhiko Kaieda 2, Shallows Tetsuro 2, Nobuo Araki 3, Teruyuki Hirano 4, Makoto Uchino 4 Neurological Therapeutics 26(3): 393-393, 2009. |
One case of the cerebrospinal fluid hypovolemia that we aggravate it after a response for 2D-05 conservative treatment again, and Brad patch needs It is still 1 light wisteria, Fumio Yamamoto 1, Yasuyuki Ito 1, Yoichiro Hashimoto 1, Yasuhiko Kaieda 2, Shallows Tetsuro 2, Nobuo Araki 3, Teruyuki Hirano 4, Makoto Uchino 4 Neurological Therapeutics 26(3): 394-394, 2009. |
Histories of treatment of two intracranial hypotension syndrome that presented the course when varied in 2D-06 田島康敬, Akihisa Matsumoto, Kazumasa Sudo Neurological Therapeutics 26(3): 394-394, 2009. |
Can 2D-07 STN-DBS improve dysuria of Parkinson disease? Tomoyuki Uchiyama 1, Takatsugu Sakakibara 2, Tatsuya Yamamoto 1, Takashi Ito will 1, Kodo Hattori 1, Satoshi Kuwahara 1 Neurological Therapeutics 26(3): 395-395, 2009. |
123I-metaiodobenzylguanidine myocardial scintigraphy in Parkinson disease that presented 2D-08 takotsubo cardiomyopathy Tsuyoshi Uchiyama, Yorozu Suzuki Ikuko, Mitsuko Ito, Takako Shimizu, Toshihiko Ohashi Neurological Therapeutics 26(3): 395-395, 2009. |
Examination of postoperative complications by the gastrostomy of 2D-09 nerves, the myopathy Kenichi Sakai 1, Daisuke Okuya 2, Futoshi Nagai person 1, Shigeto Nagao 1, Shun Haraguchi 1, Yasuyuki Tanabe 1, Yutaka Takada 1, Sincerity country Keigo 1, 井原雄悦 1 Neurological Therapeutics 26(3): 396-396, 2009. |
Trial of the half solidification nutrient in the 2D-10 nasal tube feeding tube Tsuyoshi Matsumura, Toshio Saito, Keiko Toyooka, 藤村晴俊, 神野進 Neurological Therapeutics 26(3): 396-396, 2009. |
Examination > using effect measurement <3DSRT of the TRH therapy in spinocerebellar degeneration by the 2D-11 cerebral blood flow SPECT image analysis Shigeru Kimura will, 増田曜章, Toshiro Okazaki, Yusuke Sako, Takuya Hanaoka, Kenichiro Nakamura, Ryuki Arakawa, Toshihide Kumamoto Neurological Therapeutics 26(3): 397-397, 2009. |
Utility of the handkerchief pull procedure for the 2D-12 cerebellum type exercise atactic gait Kiyomi Nanun 1, 平山惠造 2, Look at the country; Yumiko 3, Masatoshi Beppu 3, Susumu Nomura 3 Neurological Therapeutics 26(3): 397-397, 2009. |
2D-13 Pramipexole has neuroprotection effects through the astrocyte Shigeko Imamura, Takeshima Taga husband, Kazuhiro Nakaso, Satoru Ito, Kenji Nakajima Neurological Therapeutics 26(3): 398-398, 2009. |
Two cases of the pure akinesia that responded to 2D-14 serotonin 1A receptor agonist tandospirone citrate Takeshi Watanabe, Seiichi Ono Neurological Therapeutics 26(3): 398-398, 2009. |
One case of the multiple system atrophy that vocal cords abduction deficiency improved after internal use of the 2D-15 SSRI Kanako Sekiya, Ozawa iron Taro, 徳武孝允, 下畑享良, Masatoyo Nishizawa Neurological Therapeutics 26(3): 399-399, 2009. |
44 years old man case of Machado-Joseph disease where 2D-16 Baclofen intraspinal injection therapy was effective Yuka Hasegawa 1, Yoko Matsuzawa 1, 松原奈絵 1, Akiko Koike 1, Hiroshi Masuda 2 Neurological Therapeutics 26(3): 399-399, 2009. |
The activity generalization of the 2D-17 Fukuoka serious case nerves intractable disease network for 10 years and future problem Takahisa Tateishi 1, 岩木三保 2, Junichi Kira 1 Neurological Therapeutics 26(3): 400-400, 2009. |
Examination of the quality of life (quality of life)-related factor of the 2D-18 spinocerebellar degeneration (SCD) patients and the caregiver Masako Sato 1, Hitoshi Aizawa 2, Takayuki Katayama 2 Neurological Therapeutics 26(3): 400-400, 2009. |
Examination about a prognosis and breathing, the nutritional management of patients with 2D-19 multiple system atrophy Junko Suzuki 1, Maruyoshi summer British 1, Rei Kurisaki one 1, 植川和利 1, Makoto Uchino 2 Neurological Therapeutics 26(3): 401-401, 2009. |
Examination of a clinical examination and dysphagia of 2D-20 slight illness Fukuyama type muscular dystrophy (FCMD) two Hirokazu Furuya 1, Koji Ikezoe 1, 2, Joji Umemoto 3, Arahata wound 1, 1, Sakae, Araki 1, Yasuyuki Fukumaki 4, Naoki Fujii 1 Neurological Therapeutics 26(3): 401-401, 2009. |
Elution (2) of phthalate di(2-ethyl hexyl) in the gastric fistula connection tube made of 2D-21 polyvinyl chloride Is Kurata; see it; 1, Yoshihiro Wakayama 2 Neurological Therapeutics 26(3): 402-402, 2009. |
About remission maintenance treatment of 2D-22 antiMuSK antibody-positive myasthenia gravis (MG) Naoki Mabuchi 1, Yoshie Takahashi 1, Yosuke Kobayashi 1, Shin Matsumoto Jiro 2, Yasushi Kobayashi 1, Kazuhiro Imamura 1 Neurological Therapeutics 26(3): 402-402, 2009. |
Efficacy of the treatment in the Lambert-Eaton myasthenic syndrome 2 case with the 2D-23 Marie's disease Takashi Ito will 1, 米津禎宏 1, Toshihide Kanesaka 1, Kiyomi Nanun 2, Keiko Mizobuchi 3, Shigeyuki Kojima 1 Neurological Therapeutics 26(3): 403-403, 2009. |
Experience of the diaminopyridine therapy for 2D-24 serious case Lambert-Eaton myasthenic syndrome Kentaro Yamada, Height of Takeshi Yamawaki, Tetsuko Kanamori, Great Kenji Kita, Noriyuki Matsukawa, Yukio Kojika Neurological Therapeutics 26(3): 403-403, 2009. |
The Lambert-Eaton myasthenic syndrome long-term course case that 2D-25 3, 4-diaminopyridine were effective 餐場郁子 1, 齋藤由扶子 1, Atsuko Goto 1, Masakuni Kenjo 1, Akira Inukai 1, Satoshi Okuda 2, Masakatsu Motomura 3 Neurological Therapeutics 26(3): 404-404, 2009. |
Trial of the treatment for the 2D-26 chemical dystonia 中馬孝容 1, Yuichiro Matsuo 2, Kazunori Ikoma 2, Seishi Kikuchi 3 Neurological Therapeutics 26(3): 404-404, 2009. |
The hemifacial spasm (HFS) case which remitted by 2D-27 type A botulinum toxin (BTA) therapy for a long term Miki Osawa male, Shinichiro Uchiyama Neurological Therapeutics 26(3): 405-405, 2009. |
Sufferings from 2D-28 heart, the polymyositis that repeated heart failure, autopsy case of the 84 years old woman of the Sjogren syndrome Akemi Takano 1, 水谷泰彰 1, Shinichi Miyao 1, Tomoko Harada 2 Neurological Therapeutics 26(3): 405-405, 2009. |
One case of myelopathy due to the intraspinal extramedullary hematopoiesis treated effectively with 2D-29 radiotherapy Yasuhiro Hijikata, Tetsuro Ando, Osamu Kawakami, The Sugiura truth, Hiroko Kato Neurological Therapeutics 26(3): 406-406, 2009. |
NPPV therapy for the 2E-01 serious case Guillain-Barre syndrome See the head; Shuhei, 清水久央, Nobuyuki Takahashi Neurological Therapeutics 26(3): 407-407, 2009. |
It is one patient of the Guillain-Barre syndrome after the cytomegalovirus infection that resulted in abducens nerve palsy at 2E-02 re-exacerbation Megumi Ogawa Mina 1, Masahiko Kishi 1, Takatsugu Sakakibara 1, Michiaki Koga 2 Neurological Therapeutics 26(3): 407-407, 2009. |
One case of the GM1/GQ1b complex antibody-positive Guillain-Barre syndrome improved by a repeated dose of the 2E-03 gamma globulin Wataru Atsumi 1, Toshihiko Araki 1, Kenji Miki 1, Harumi Ishikawa 1, 楠進 2 Neurological Therapeutics 26(3): 408-408, 2009. |
One case of the Guillain-Barre syndrome that was complicated with pulmonary embolism after 2E-04 IVIg therapy, and took the exitus 清水洋孝, Yasushi Kita Neurological Therapeutics 26(3): 408-408, 2009. |
Kinetic neuropathic one patient who beginning of 2E-05 motor neurone disease was suspected, and responded to IVIg Hirotsugu Mikami, Seiichi Ono Neurological Therapeutics 26(3): 409-409, 2009. |
One case of acute motor sensory axonal neuropathy where 2E-06 intravenous immune globulin therapy (IVIg) was effective Hirotsugu Mikami, Seiichi Ono Neurological Therapeutics 26(3): 409-409, 2009. |
One case of tuberculous meningitis, the tuberculoma that it was thought that 2E-07 QuantiFERON and FDG-PET were useful for a diagnosis and an evaluation of the condition Isaki Sachiko, Takafumi Iguchi, Takashi Tajima person, Shinya Narikawa, Takako Iguchi, Takao Mitsui, Manabu Onuki, Kyoichi Nomura Neurological Therapeutics 26(3): 410-410, 2009. |
43 years old man case of tuberculous meningitis treated effectively with isoniazid(INH) intraspinal injection with 2E-08 intractable hydrocephalus Daigo Hayashi, Ayako Kuriki, Masayuki Sugie, Kenji Ishihara, Mitsuru Kawamura Neurological Therapeutics 26(3): 410-410, 2009. |
Prognosis in the duration of steroid use of bacterial meningitis in the 2E-09 this hospital, examination about complications Plum Tokyoku 1, Chikako Kaneko 1, Jin Kubo 1, 下地眞哉 1, Tetsuya Ishihara 1, Koichi Hirata 2, Teiji Yamamoto 1, Soichi Katayama 1 Neurological Therapeutics 26(3): 411-411, 2009. |
Clinical analysis of five 2E-10 tuberculous meningitis Futoshi Nagai person 1, Kenichi Sakai 1, Naoko Katayama 1, Shigeto Nagao 1, Shun Haraguchi 1, Yasuyuki Tanabe 1, Yutaka Takada 1, Sincerity country Keigo 1, 井原雄悦 1, Noriko Kawata 2 Neurological Therapeutics 26(3): 411-411, 2009. |
Course and prognosis of tuberculous meningitis that we experienced in 2E-11 this hospital Tomoko Noda, Rina Hashimoto, Satoshi Okuda, Eiichiro Mukai Neurological Therapeutics 26(3): 412-412, 2009. |
About the combination of three - steroids of the hypertrophic cranial pachymeningitis with 2E-12 aspergillas infections - 奥村幸祐, Masaru Yamashita, Tomoo Hirahara, 岡本定久, Makoto Nakajima, Sei Watanabe tree, Madoka Kimura, Taro Yamashita, Yasushi Maeda, Teruyuki Hirano, Makoto Uchino Neurological Therapeutics 26(3): 412-412, 2009. |
One case of the cryptococcus meningitis with the multiple bone lesion which we were able to consult with about remission by 2E-13 L-amphotericin B chronic administration Nakamura example line Neurological Therapeutics 26(3): 413-413, 2009. |
One case of toxoplasmic encephalitis that developed in 2E-14 Immunocompetent host Great seal Masako, Takahiro Saegusa, Katsuya Kobayashi, 渡邉究, Yoshifumi Nakatani, Yukio Miyazaki Neurological Therapeutics 26(3): 413-413, 2009. |
One case of rheumatic meningitis that 2E-15 steroid-pulse therapy showed improvement by steroid downward titration with resistance Nakajima name Ritsuko 1, Noburu Saito intellect 1, Harumi Ishikawa 1, Tomohiro Naganuma Kei 2, Masaki Ishihara 3, Kenji Miki 1, Toshihiko Araki 1 Neurological Therapeutics 26(3): 414-414, 2009. |
Three cases of the brain abscess that 2E-16 Linezolid was effective Kanzaki Akihiro, Yoshito Tanaka, 好永順二, An upper profit very much Neurological Therapeutics 26(3): 414-414, 2009. |
Utility of the 2E-17 aseptic meningitis pass 眞野智生, Yasuhiro Hasegawa, Keizo Yasui, Yusuke Fujioka, Araki lap Neurological Therapeutics 26(3): 415-415, 2009. |
Three patients who presented with brachial plexopathy after 2E-18 median sternotomy open heart surgery Yasushi Kita, 清水洋孝 Neurological Therapeutics 26(3): 415-415, 2009. |
One patient whom single neuropathy more multiple than 2E-19 bone marrow transplantation one year later developed, and relapse of leukemia was diagnosed in several months later 徳山承明, 白石眞, Toshikazu Hirayama, Yasuhiro Hasegawa Neurological Therapeutics 26(3): 416-416, 2009. |
One case of peripheral neuropathy due to the malignant lymphoma that 2E-20 PET was effective for effect measurement of a diagnosis, the treatment Satoko Nakashita 1, Rei Kobayashi 1, Eiichiro Mukai 1, Haruhiko Ohashi 2 Neurological Therapeutics 26(3): 416-416, 2009. |
One case of the paraneoplastic limbic encephalitis with the small cell lung cancer which 2E-21 higher brain function improved remarkably Kazuyo Ikeda 1, Kazushi Deguchi 1, 塚口眞砂 1, Tetsuo Toge 2 Neurological Therapeutics 26(3): 417-417, 2009. |
One case of the central nervous system primary malignant lymphoma which racked the brains about 2E-22 diagnosis, and was not able to lead to earlier treatment Kenzo Sakurai, Kinaoshi, Saza, 下邨華菜, Kanako Shimizu, Kikuko Shiobara, Hiroshi Sasaki I, 加藤文太, Country incense Naoya, Toshikazu Hirayama, Yasuhiro Hasegawa Neurological Therapeutics 26(3): 417-417, 2009. |
One case of the empyema-related lymphoma detected for 2E-23 acute transverse myelopathy Tetsuro Ishihara, 近藤直英, 渡辺宏久, Naoki Hattori, Origin of Sofue Neurological Therapeutics 26(3): 418-418, 2009. |
One case of intravascular lymphoma(IVL) which it occurred near 2E-24 conus medullaris and was able to diagnose by bone marrow biopsy Shin Matsumoto Jiro 1, 山下史匡 1, Naoki Hattori 1, Sofue former 1, Nobuaki Suzuki 2, 中山亨之 2 Neurological Therapeutics 26(3): 418-418, 2009. |
Use experience of edaravon for the hypoxic encephalopathy by the 2E-25 hanging Kenichi Kawada, Kiyomi Oodate Neurological Therapeutics 26(3): 419-419, 2009. |
Examination about the early diagnostic method using the diffusion tensor analysis of the 2E-26 intermission type carbon monoxide poisoning Kuroda sky 1, Kazuo Fujiwara 1, Michio Kobayashi 2, Shino Yotaro Sawa 2, Yasuto Itoyama 1 Neurological Therapeutics 26(3): 419-419, 2009. |
One case of rhabdomyolysis with a cutis symptom and peripheral neuropathy by the combination of 2E-27 Rosuvastatin and clarithromycin Makoto Nomura, Seiichi Ono Neurological Therapeutics 26(3): 420-420, 2009. |
Neuropathic one case that occurred after 2E-28 Bupivacaine spinal anesthesia Hiroshi Shiota, Motohiko Hara, Tomohiko Mizutani Neurological Therapeutics 26(3): 420-420, 2009. |